Back to results
US 2022/0088181 A1Published application
Virus specific cytokine-induced killer cells
AssigneeAbteilung für Integrierte Onkologie - CIO Bonn
InventorIngo Schmidt-Wolf
Life of this patent
Estimating the term…
Abstract
The present invention is directed to Virus specific Cytokine-Induced Killer cells (CIK), their use as a medicament and to a method for obtaining these Virus specific Cytokine-Induced Killer cells.
Claims20
Virus specific Cytokine-Induced Killer cells (CIK), obtainable by co-culturing a CIK with at least one other population of eukaryotic cells that have been pulsed with viral antigens.
A method for preparing Virus specific Cytokine-Induced Killer cells, comprising the step of co-culturing a CIK with at least one other population of eukaryotic cells that have been pulsed with viral antigens.
Dependencies are inferred from the claim text.